EDGAR Verified
Primary Source · SEC.gov

EquityZen Growth Technology Fund LLC - Series 1793

CIK 0001990371Single-Deal SPV2023 vintage506(b), 3(c)(1)

Raised

$283K

Investors

14

Min Invest

$10,004

AltStreet Analysis

·

Generated from EDGAR primary sources

EquityZen Growth Technology Fund LLC - Series 1793 is a Delaware pooled investment vehicle filed by EquityZen Advisors LLC and Phil Haslett, raising $283K from 14 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This is an amended filing for a pre-IPO fund vehicle within the EquityZen platform, which operates 1,889 related EDGAR entities focused on private company equity access.

This pre-IPO pooled fund uses the standard 506(b) and 3(c)(1) exemption structure typical of platforms offering retail-accessible private growth equity. The $10K minimum represents the lower end of alternative investment minimums, consistent with EquityZen's model of democratizing access to pre-IPO companies through series-specific SPVs.

Data Flags

investor_count14 investors contributing an average of approximately $20K each, suggesting relatively uniform small check sizes for a pre-IPO vehicle

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001990371
Entity NameEquityZen Growth Technology Fund LLC - Series 1793
Exemption506(b), 3(c)(1)
First Sale Date
Filing DateDecember 5, 2023
Accession Number0001990371-23-000002
Total Amount Sold$283K
Total Investors14
Minimum Investment$10,004
Securities TypeEquity, Pooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

EquityZen Advisors LLC

Executive Officer, Director · New York, NY

Phil Haslett

Executive Officer, Director · New York, NY

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.